We have provided a recording of the event below:
For our first Speaker Series event of the 2017-2018 academic year we are excited to present a stimulating discussion on the legal and ethical ramifications of stem cell research. This event will present diverse perspectives on research involving the development, use and destruction of human embryos, as well as its many potential benefits and its complexities and regulations.
Speakers include:
Dr. William Stanford, Ottawa Research Institute:
Dr. Stanford is a leading stem cell researcher focusing on understanding and manipulating human embryonic stem cells for development of novel therapeutics for many human diseases including cancer.
Me. William Brock:
A partner at Davies who is also a leukemia survivor that underwent stem cell treatment. Me. Brock will give us his legal and personal perspective on the technology.
Dr. Michel L. Tremblay:
Dr. Tremblay is a leading researcher in the Biochemistry Department at McGill University. Dr. Tremblay will discuss techniques for modifying stem cells using CRSPR-Technology in the lab as well as the current use of stem cells in the clinic. Dr. Tremblay will also discuss pertinent ethical issues such as who owns stem cells, stem cell “tourism”, and the future of stem cells including drug development, use of stem cells for tissue/organ replacement and stem cells versus robotics-cybog.
The event will take place at the Thompson House Restaurant (3650 Mc Tavish, Montreal) on November 1st 2017 from 4:45 PM until 6:00 PM. No tickets required. Please arrive 10 minutes in advance to secure a seat.
McGill Journal of Law and Health 